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Industrial chemicals, pesticides and other similar compounds are all known to be a burden for 
the environment. In high concentrations they can all affect the biological environment in a 
manner that is dangerous for organisms. The presence of pharmaceuticals and personal care 
products (PPCPs) in the environment are of great interest regarding to their potential toxicity. 
Pharmaceuticals and PPCPs are discovered in soil, sludge, sewage and in the adjacent aquatic 
environment. 
The aim of this study was to develop and optimize a hollow fiber liquid- phase 
microextraction (HF-LPME) method for extraction and pre-concentration of benzodiazepines 
and its metabolites in sewage water. Different parameters like donor- and acceptor phases, 
fibers and organic phases were to be tested. It is preferred to perform extraction without the 
use of synthetic organic solvents. An organic phase using e.g. plant oils possess lower health 
risk, lower costs and have no restrictions regarding deposition. Different plant oils, essential 
oils and volatile oils were therefore tested as organic phase.  
The compounds that was to be investigated in this study were chosen by looking at sales 
statistics for benzodiazepines in Norway over a three years period, 2005-2007[1]. Some 
metabolites of the compounds were also included. The chosen compounds were zopiclone, 
zopiclone-d8, zopiclone N-oxide, N-desmethyl zopiclone hydrochloride, zolpidem, zolpidem-
d6, alprazolam, alprazolam 5-oxide, 1-hydroxy alprazolam, midazolam, midazolam –d5 and 
1`-hydroxy midazolam.  Later in the project clonazepam and 7-aminoclonazepam were 
included.   
Sewage water samples were collected at Langnes Sewage Treatment Plant (STP), Tromsø, 
before they were filtered and extracted by hollow fiber liquid phase microextraction and 
analysed on Ultra Performance Liquid Chromatography- Mass Spectrometry/ Mass 
Spectrometry (UPLC- MS/MS).  
Quantifiable amounds of zolpidem was found during the collection in January, midazolam 
and 1- hydroxyl midazolam were detectable. In April 1- hydroxy midazolam, midazolam and 
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Persistent organic pollutants (POP`s) and other compounds have for many years been 
investigated regarding their influence on the environment. Most POP`s found are products 
from industrial production all over the world e.g. Dichlorodiphenyltrichloroethane (DDT) 
used in insecticides[2]. 
The general definition of environmental pollutants is substances that have high acute toxicity, 
tendencies to undergo bioaccumulation and biomagnifications. They also have a high 
resistance against degradation and long half life in the environment. A longer time of 
exposure heightens the risk for multiple contamination of the ecosystem[3].  POP`s become 
widely distributed geographically and can accumulate in the fatty tissue of living organisms. 
The international community has called for urgent global actions to reduce and eliminate the 
release of these chemicals to the environment. Another concern is pharmaceuticals found in 
environmental samples.  In 1999, over 50 individual pharmaceuticals and personal care 
products (PPCP) or their metabolites had been identified in environmental samples[4]. The 
finding of pharmaceuticals in environmental samples like sludge, soil, sewage water and 
adjacent seawater has the last years increased the concern of environmental toxicity. Studies 
regarding environmental toxicity have shown adverse effects on non target organisms in the 
presence of pharmaceuticals[3]. The list of pharmaceuticals found in environmental samples 
is increasing, but our knowledge towards the toxic effect they exhibit on wildlife and other 










3.1 Pharmaceuticals in the environment 
The last decade the consumption of pharmaceuticals has increased extensively.  
In 2008 is was consumed drugs for about 17,6 billions NOK or about 3700 NOK per 
inhabitant in Norway[5]. There where 1882 pharmaceuticals in the Norwegian market,  
1447 different active compounds[6]. Pharmaceuticals have several pathways of entering the 
environment. Human and veterinary pharmaceuticals are the main source of pharmaceuticals 
and their metabolites in the environment. The pharmaceuticals reach the environment through  
mainly excretion of urine or faeces[2]. Before excretion pharmaceuticals are metabolized to a 
certain extent. They can be structurally modified bye germs in the stomach/ intestine or by 
enzymatic degradation in the liver. The metabolism may lower activity and enhance water 
solubility, however in the case of pro-drugs activation occurs. Another way of entering the 
environment is by chemical dumping. In stead of returning unused pharmaceuticals to the 
pharmacy, who is responsible for destruction, people use inappropriate disposals as toilets, 
sinks and garbage. According to the Norwegian Medicines Agency should all applications for 
marketing license include an assessment regarding possible environmental toxicity. 
Marketing license of veterinarian pharmaceuticals may be denied if the compound has shown 
environmental toxicity[7].       
Pharmaceuticals are complex molecules, developed and used because of their specific and 
high biological activity[3].  Because of this specificity and high stability they might have the 
opportunity to cause harm in even lower concentrations than other POP`s detected in the 
environment. Most pharmaceuticals do not have an acute toxicity in the concentration ranges 
found in environmental samples. However, their ability to accumulate and the low dose long-
term exposure may affect non target organisms. There have previously been detected 
pharmaceuticals in waste water, soil, sludge, adjacent seawater and even in drinking water. 
Contraceptives, anti depressants and antibiotics have all previously shown adverse affects on 
fish and other non target organisms[3].   
The knowledge about how pharmaceuticals affect the environment is limited, especially when 
it comes to understanding the long-term effects of exposure. Until now the general possible 
effects of only a few pharmaceuticals have been studied. More studies regarding 
pharmaceuticals in the environment have to be performed in the future to truly understand 
their effects.   
___________________________________________________________________________ 
3.2 Benzodiazepines 
According to the Norwegian health institute, 670.000 Norwegians were prescribed a 
benzodiazepine or benzodiazepine like drug in 2007. Benzodiazepines are by far the most 
commonly prescribed hypnotics. Drugs that affect the nervous system, like benzodiazepines, 
represented one fifth of the total amount drugs prescribed in Norway, 2008[8]. They all have 
sedative/hypnotic, anxiolytic, amnesic, muscular relaxant and anticonvulsant actions with 
minor differences in the relative potency of these effects[9, 10]. Hypnotics are generally 
intended for short- time use, they are discontinued as soon as possible. As class 
benzodiazepines has been associated with abuse and dependence. Hangover effects at higher 
dosages, including drowsiness, confusion, and lack of coordination and slowed reaction time 
are all registered adverse effects using benzodiazepines. The benzodiazepines exert their 
action on specific benzodiazepine receptor sites in the body, gamma- aminobutyric acid 
A(GABA A) receptors[2].These receptors mediates fast inhibitory synaptic transmission 
throughout the central nervous system. The many side effects observed using 
benzodiazepines has resulted in the development of a number of alternatives. These newer 
drugs are structurally different from the benzodiazepines and have a short time of duration, 
but act at the same or similar receptor sites as the original benzodiazepines. Zopiclone and 
Zolpidem are examples of such newer drugs. They are chemically unrelated to 
benzodiazepines but have the same pharmacological effect[2, 9]. Because of fewer side 
effects, Zopiclone is the most prescribed benzodiazepine in Norway.  
The basic chemical structure of benzodiazepines consists of a seven- membered ring fused to 
an aromatic ring. The aromatic ring has four main substituent groups that can be modified 
without loss of activity(R), see figure 1[11]. 












3.3 Liquid phase microextraction 
LPME has been used as extraction technique of analytes since 1996. 
The first method developed was two- phase microextraction. This method is based on a single 
droplet organic solvent hanging from a micro syringe needle. The droplet was placed in an 
aqueous sample for extraction based on passive diffusion from the aqueous sample into the 
organic phase. The organic solvent was then withdrawn into the syringe and injected into the 
GC-MS.  
                                                       A Sample ↔ A Acceptor 
 
In 1999 a new LPME technique was developed, Hollow Fiber Liquid Phase MicroExtraction 
(HF-LPME). HF-LPME presents better extraction efficiency and sensitivity compared to 
two- phase microextraction. The HF-LPME system could consist of two- or three- phases. In 
a two phase system the analyste in the aqueous sample are extracted into an organic solvent 
immobilized in the pores and the lumen of the fiber.  
The three- phase system consists of an aqueous sample with analytes, which are extracted 
from the aqueous sample through a thin film of organic solvent in the pores of the hollow 
fibre, and into an aqueous acceptor phase. 
The LPME method is suited for analytes, acidic or basic, with ionizable functional groups.  
For extraction of basic compounds like benzodiazepines, the pH of the sample has to be 
adjusted into the alkaline region to promote extraction into the organic phase. To promote 
high extraction efficiency from the organic phase into the acceptor phase, the pH in the 
acceptor phase is adjusted to a low acid region [12-15]. In addition the extraction is carried 
out with stirring at 800 rpm to promote the diffusion.  
Liquid phase microextraction is known to perform high pre-concentration and sample clean-
up[16]. The basic set-up for three-phase LPME is illustrated in figure 2. 
 




Figure 2: Three-phase Liquid phase microextraction of a basic drug [17]. 
 
Selection of organic phase 
The organic solvent used to fill the pores of the hollow fiber plays an important role in three-
phase LPME, effecting both recoveries and extraction kinetics. Low volatility to prevent 
evaporation, low polarity to ensure compatibility with the hollow fiber and to prevent leakage 
into the sample, and low viscosity to ensure rapid mass transfer are important qualities looked 
for in an organic phase used for this purpose. The organic solvent should also provide high 












3.4 Ultra performance liquid chromatography 
During liquid chromatography a mobile phase is pushed through a column packed with a 
material for separation of the analytes in the sample. The sample is injected into the mobile 
phase before the entrance of the column. The columns used are usually 5-25 cm long, their 
task together with the mobile phase is to separate the analytes in the sample[18]. Typically 
the stationary phase of an UPLC- column has spherical particles with smaller diameter than 
the particles used in HPLC- columns.  Narrower column and smaller sorbent particles 
contribute to better sensitivity and lower detection limits.   
UPLC is known to give increased resolution and narrower peaks, compared to HPLC. 
Narrower peaks may result in better sensitivity depending on the selected detector. The 
sample run may be made more efficiently and therefore making UPLC a more cost-effective 
method[19]. 
Reverse phase is the most used separation technique in liquid chromatography. It consists of 
a hydrophobic stationary phase (column) and a hydrophilic mobile phase. The more 
hydrophobic the compounds, the more they are adsorbed to the hydrophobic stationary phase. 
The stronger the analytes are adsorbed to the stationary phase, the longer is the retention time 
for the compound [18].  C8 (octyl) or C18 (octadecyl) bonded silica-based materials is the 
most used reverse phase columns.    
Selection of mobile phase 
Liquids used as a mobile phase should be; non reactive, have low viscosity, a certain purity 
degree and not be flammable. Low viscosity ensures that the pressure in the HPLC- system is 
kept at low levels. Water, methanol and acetonitrile are among the most frequently used 
liquids in reverse phase columns. In order to optimize the ionization of the analytes the pH of 




3.5  Mass Spectrometry  
During electrospray ionization the sample is transformed to an aerosol. This is done by 
applying high voltage to the capillary. Nitrogen is used as an assistant to improve the 
nebulization. By the outlet of the stainless steel capillary the aerosol passes a cylindrical 
electrode. Between the capillary and this electrode there is a potential of e.g. 3- 3,5 kW, 
which charges the aerosol (see figure 3). When the source is operated in positive- ion mode 
the analytes receives a positive charge. During the analytes flight between the ESI (electro 
spray ionisation) steel capillary and the entrance of the MS, neutral solvent molecules 
evaporate from the surface of the droplet. This results in a decrease of the droplet size and a 
charge- transfer to the analytes. This gas phase ions is led into the MS by an optimized 
electric voltage.  Electric voltage on the cone is optimized in order to guide the analyte ions 
into the mass spectrometer without causing unnecessary fragmentation in the ion source.     
 
 







MS/MS:    
Mass spectrometry is a specific and sensitive method, used for both quantitative and 
qualitative messurements. During mass spectrometry the analytes are ionized and separated 
by the mass- to –charge ratio(m/z)[18]. The MS used in this study contain three quadrupoles 
(Q1,q and Q2), in MRM- mode.  Q1 is set to only pass the ions with the right molecular 
weight. In the collision cell the analytes are fragmented by a non-reactive collision gas 
(Argon gas). In Q2 the mass of the fragments are measured, and the most intense product ion 
is selected for quantitative measurements. See figure 4. 
 
 









3.6 Limit Of Detection and Limit Of Quantification 
The Limit Of Detection (LOD) is the lowest concentration at which the analyte with certainty 
can be detected in the sample analyzed with the given method. The analyte could be detected 
if the concentration is the same or higher than the LOD.  
The Limit of detection is affected by sample content, volume of injection, solvent used and 
efficiency of the separation of the peaks. The extraction method may affect the LOD by the 
different parameters tested in the three- phase system e.g. pH of the donor- and acceptor 
phase and organic solvent. The presence of unwanted particles and other objects in the 
sample may also affect the LOD.  
LOD is determined by measuring the signal- to – noise ratio(S/N) in the sample with a given 
concentration. Limit of detection is defined as S/N≥ 3. S is the height of the signal and N is 
the height of the noise.   
                    LOD = concentration of analyte in the sample (ng/1,1L) x 3 x Noise (cm)  
                                                                                                                        Signal (cm) 
Limit Of Quantification (LOQ) is defined as the lowest concentration analyte that could be 
determined with an acceptable precision. It is a compromise between the concentration and 
the precision. The analytical results usually differ more widely when the analyte 
concentration is low. LOQ is determined the same way as LOD, but the quantification limit is 
defined as S/N ≥ 10[18].  
                   LOQ = concentration of analyte in the sample (ng/1,1L) x 10 x Noise (cm)  







3.7 Sewage treatment plants 
Waste water treatment usually consist of three main steps; physical, chemical and biological 
cleaning. The sewage treatment plant (STP) Langnes, Tromsø, where samples have been 
collected consist only of physical cleaning. Physical cleaning together with chemical and 
biological cleaning is the preferred method. 
The only barrier between the sewage and the outlet of the sewage treatment plant at Langnes 
is a 300 µm filter. During the filtration a huge quantity of sludge is obtained and delivered to 
composing. Physical cleaning of sewage water does not clean the outlet sewage water 
hundred percent, but measurements of samples taken from the outlet of the STP regarding 
outlet of sewage into the environment do not cross the regulations of permitted waste.  
STP Lagnes receives waste water from households and business segments[20]. One section 
of the universital hospital in Tromsø, Åsgård, is also connected to Langnes sewage treatment 
plant. Benzodiazepines are widely used as sedatives at hospital awards like this. The 
connection of a hospital award could influence the amount benzodiazepines found in the 
sewage water[21].                
 





AIM OF THE THESIS 
The aim of this thesis was to develop and optimize a Hollow Fiber- Liquid Phase 
MicroExtraction (HF-LPME) method for extraction and pre- concentration of 
benzodiazepines and metabolites in sewage water. The method should be optimized by 
performing HF-LPME with different organic solvents, essential oils, volatile oils, food oils, 
bases and acids, pH and hollow fibers. There has to my best knowledge never been 
performed analysis of Benzodiazepines in the environment by HF- LPME. 






4 MATERIALS AND METHODS 
Chemicals  
Zopiclone  (4-Methyl-1-piperazine-carboxylic Acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-
oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl Ester),      Zopiclone-d8 ( 4-Methyl-1-piperazine-d8-
carboxylic Acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl 
Ester) ,     Zopiclone N-Oxide (1-Piperazine-carboxylic Acid 4-Methyl-4-oxide 6-(5-Chloro-
pyridin-2-yl)-7-oxo-6,7-dihydro-5H pyrrolo[3,4-b]pyrazin-5yl Ester),     
N-desmethyl Zopiclone Hydrochloride  (Piperazine -1-carboxylic Acid 6-(5-Chloro-pyridin-
2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5yl Ester) ,     Zolpidem (N,N,6-
Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyrimidine-3-acetamide) ,      Zolpidem-d6 
(N,N,6-Trimethyl-d6-2-(4-methylphenyl)imidazo[1,2-a]pyrimidine-3-acetamide), 
Alprazolam (8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine), 
Alprazolam 5-Oxide( 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine 
5-Oxide),    1-hydroxy Alprazolam (a-Hydroxyalprazolam),      Midazolam (8-Chloro-6-(2-
fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine),      Midazolam –d5 (8-
Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-d5) and           
1`-hydroxy Midazolam (a-Hydroxymidazolam; 8-Chloro-6-(2-fluorophenyl)-1-
hydroxymethyl-4H-imidazo[1,5a][1,4]benzodiazepine) were purchased from Toronto 
Research Chemicals (TRC, Toronto, ON, Canada). Clonazepam(50[2-Chlorophenyl]-1-3-
dihydro-7-nitro-2H-1,4-benzodiazepin-2-one) and 7-Aminoclonazepam (7-Amino-5-[2-
chlorophenyl]-1-3-dihydro-2H-1,4-Benzodiazepin-2-one)were purchased from Lipomed AG 
(CH-4144 Arlesheim, Switzerland). 
Solvents for UPLC were Acetonitrile, isocratic grade for liquid chromatography (Merck, 
Darmstadt, Germany), Formic acid 98-100% pro analysi (Merck), Methanol(Merck) and 
water from a MilliQ purification unit from Millipore(Bedford, Massachusetts,USA). 
 
Solvents for the hollow fiber liquid phase microextraction were; 3-octanol (Fluka AG, Buchs 
SG, Switzerland), 1-octanol (Sigma-Aldrich, Steinheim, Germany), Dihexyl ether (Sigma-
Aldrich). Corn oil, Sesame oil( Naturata), Rape(seed)oil, cold-pressed(Odelia) and Sunflower 
oil were all purchased from Coop, Norway.  
___________________________________________________________________________ 
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The essential oils; Almond oil (Pharmacy production, Oslo, Norway) and Peanut 
oil(Pharmacy production) and the volatile oils; Peppermint oil(Pharmacy production), 
Eucalyptus oil(Pharmacy production).  
Sodium hydroxide pellets, GR for analysis (Merck). Formic acid 98-100% pro 
analysi(Merck), Ammonia Solution 32% (Merck), Hydrocholric acid fuming 37% 



























pKa: 6,79 ± 0,42
CAS reg.nr.:43200-80-2
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    1-Hydroxy Alprazolam
     Mon.masse:324,07
     pKa=1,24±0,40
    Cas.reg.nr.:37115-43-8




















           Midazolam-d5           
       Mon.masse:330,11
          pKa=5,56±0,40
     Cas.reg.nr.:59467-70-8







  1-Hydroxy Midazolam
   Mon.masse:341,07
   pKa= 4,39±0,40
   CAS reg.nr.:59468-90-5
 
 
                                             
      





















CAS.reg.nr.:4959-17-5                     
                                                             





Preparation of Stock solutions and real samples  
Stock solutions of each benzodiazepine and metabolite were prepared separately by 
dissolving proper amounts of each drug in HPLC grade methanol in concentrations of 50 or 
100µg/mL. The Stock solutions were stored dark at -18 ºC. 
Further, each Stock solution were diluted with a solution consisting of Millipore water  
(50 %), formic acid (0,1 %) and methanol (49,9 %) reaching a concentration of 1µg/ml of 
each compound. This diluted solution was used to tune the MS/MS parameters. 
Further, a mixed Stock solution was prepared (25ng/mL) by diluting proper amounts of each 





Wastewater samples were collected at Langnes STP, Tromsø, Norway. This sewage 
treatment plant uses an automatic sampling system to collect sample over a given period of 
time (picture 2). This is done to ensure that the collected sample is representative of the total 
amount sewage over a period of 24 ours.  
 
                          





5 Method development of Liquid Phase MicroExtraction  
Previous studies using HF-LPME as an extraction method of different analytes has shown 
good results. Extraction of both large sample amount e.g. 1,1 L adjacent seawater and small 
amounts e.g. 0,2 - 1mL water, plasma and urine have previously been performed with success 
[15, 21, 22]. No articles have been found regarding HF-LPME of benzodiazepines in 
environmental samples.  
The HF-LPME method developed for extraction of basic antidepressants by Terje Vasskog 
was used as a basis[21]  and further optimized in order to perform the best extraction of the 
selected benzodiazepines.  
 
Equipment 
Medical syringe needles used during LPME; Terumo 0,5 x 16mm, 25G x 5/8” and  
BD Microlance 3, 0,8 x 25mm, 21G x 1”. 
Hollow fibers used during LPME;  
- Capillary Membrane (Type P1 LX), polypropylene: Inner diameter 330 µm, wall thickness 
150 µm, bubble point 1,31 bar, transmembran flow 9,3 ml/[min x cm2 x bar] and pore size 
max 0,47 µm.  
- Hydrophobic capillary membrane(Type PP Q3/1), polypropylene: Inner diameter 600 µm, 
wall thickness 200 µm, bubble point 1,36 bar, transmembrane flow 2,1 ml/[min x cm2 x bar]  
and pore size max 0,44 µm.  
- Hydrophobic capillary membrane(Type PP Q3/2), polypropylene: Inner diameter 600 µm, 
wall thickness 200 µm, bubble point 0,95 bar, transmembrane flow 5 ml/[min x cm2 x bar]  
and pore size max 0,63 µm.  




A hollow fiber was used to connect two medical syringe needles. The hollow fiber was 
dipped in an organic solvent, for about 20 seconds to fill the pores. Then an ultrasonic bath 
was used for about 3 seconds to remove excess solvent. After every third fiber, the water in 
the ultrasonic bath was changed. A 1 mL syringe was then attached to one of the medical 
syringes and used to fill the lumen of the hollow fiber with acidic acceptor solution (picture 
3). The medical syringe needles were then removed and the ends of the hollow fibre were 
closed by a thin copper wire.                                                                                      
 
 
             Picture 3: Demonstration of how to add acceptor solution into the lumen of the hollow fibre. 
 
The HF- LPME was carried out in a 1000 ml glass bottle. 1,1 L tap water were added a given 
concentration of the analytes and made basic.  
Screw cap with septum was used to close the bottle. A 0,8 mm syringe was inserted through 
the septum, and a thin metal wire was used to hold the fiber down in the water during the 
extraction (picture 4). The extraction was carried out with stirring at 800 rpm for 2 hours.   
32
___________________________________________________________________________ 
After extraction the acceptor solution was collected in a UPLC autosampler vial. This was 
done by attaching a 1 mL syringe with a medical syringe needle to one end of the fiber before 
air was used to push the acceptor phase through the fiber into the vial. The acceptor solution 
was directly injected to the LC-MS/MS. Each fiber was only used once. 
 
 






Optimization of method 
In order to optimize the method different organic solvents, essential oils, volatile oils, food 
oils, acides and bases, pH in the acceptor and donor phase, and 3 types of fibers were tested. 
5.1.1 Hydrolysis of Zopiclone and metabolites  
During the beginning of the method development it was discovered that zopiclone,  
zopiclone-d8, N-desmethyl zopiclone and zopiclone N-oxide were not detected on the MS 
during the analysis, after extraction. Because of the molecular structure of zopiclone and its 
metabolites we suspected basic hydrolysis of the molecule. See figure 6 for suspected point 
of attack. To confirm this, zopiclone, zopiclone- d8 and N- desmethyl zopiclone were added 
to three different solutions; water adjusted to pH 2 with formic acid, water adjusted to pH 
10,5 with ammonia and one solution of pure Millipore water. The three samples were then 
injected to the UPLC-MS/MS. Zopiclone N- oxide was hard to detect on the MS, it was 













           Zopiclone  
Figure 6: Molecular structure of zopiclone and suspected point of attack, during basic hydrolysis.    
 
After indications in the chromatograms that basic hydrolysis occurred, the solution with 
water adjusted to pH 10,5 with ammonia was infused directly into the MS to obtain a full 
scan.  
The molecular weight of the products made after hydrolysis of zopiclone, zopiclone- d8, N-
desmethyl zopiclone and zopiclone N-oxide was calculated and searched for in the full scan.  




hydrolysis of the molecules is therefore not suspected. This analytes contain some nitrogen’s 
that are suspected to protect the molecule from undergoing acidic hydrolysis.      
 
5.1.2 Extraction using different organic phases 
Previously performed HF-LPME extractions have given good results using different organic 
phases. Plant oils, essential oils and traditional LPME solvents (dihexyl ether, n- octanol and 
dodecyl acetate) have all previously been used as intermediate extraction medium from 
different aqueous samples (water, plasma and urine) with a volume of 0.2 to 1 mL [22].  
The traditional LPME solvents, dihexyl ether and 1- octanol have previously also been tested 
on large samples waste water and adjacent seawater(1,1 L) [16].   
Essential oils and plant oils have the advantage of lower costs than the traditional LPME 
solvents. They are safer to work with and do not have to be disposed with special care.   
In order to optimize the developed method for extraction of benzodiazepines using  
HF-LPME, different organic phases like traditional LPME solvents, 1- octanol, 3- octanol 
and dihexyl ether were tested. These traditional organic solvents were also replaced by 
essential almond oil and peanut oil. Two volatile oils; peppermint oil and eucalyptus oil, and 
plant oils used for cooking; corn oil, sesame oil, rape (seed) oil and sunflower oil was also 
tested as organic phases. Sesame oil and peanut oil has to my best knowledge never been 
used as organic phase during extraction with HF- LPME.   
The extraction was carried out as previously described, using water adjusted to pH 12.65 with 
sodium hydroxide as donor phase and water adjusted to pH 2 with formic acid as acceptor 
phase. These conditions were chosen because of good results during extraction of selective 
serotonin reuptake inhibitors in environmental samples [21]. Three parallels of each 





5.1.3 Extraction using different bases as donor phase 
HF-LPME was not a successful extraction method for all the selected analytes. Clonazepam,  
7-amino clonazepam, alprazolam and 1-hydroxy alprazoalm were not extracted using water 
adjusted to pH 2 with formic acid as acceptor phase and water adjusted to pH 12.65 with 
sodium hydroxide as donor phase. These mentioned analytes have lower pKa- values than the 
analytes that successfully were extracted. Therefore it was suspected that the analytes were 
not sufficiently basic, in order to be transported through the organic phase.  
Because of this it was decided to try two different bases as donor phase; water adjusted to pH 
13.95 with sodium hydroxide and water adjusted to pH 11 with ammonia.    
The extraction was carried out as previously described, water adjusted to pH 2 with formic 
acid was used as acceptor phase and dihexyl ether was used as organic phase. 
Three parallels of each concentration, 250, 100 and 50 ng analytes were extracted and 
injected to the LC-MS/MS. 
 
5.1.4 Extraction using different acids as acceptor phase  
Clonazepam, 7-amino clonazepam, alprazolam and 1-hydroxy alprazoalm were not detected 
on the MS/MS after extraction using water adjusted to pH 2 with formic acid as acceptor 
phase, dihexyl ether as organic phase and water adjusted to pH 12.65 with sodium hydroxide 
as donor phase.  
It was suspected that some of these analytes were not properly ionized in the acceptor phase 
which leads to poor extraction. It was therefore decided to try two different acids as acceptor 
phase, water adjusted to pH 1 and pH 2 with hydrochloric acid and water adjusted to pH 2 
with formic acid. The extraction was carried out as previously described using water adjusted 
to pH 12.65 with sodium hydroxide as donor phase and dihexyl ether as organic phase.  
Three parallels of each concentration, 250, 100 and 50 ng analytes were extracted and 




5.1.5 Optimized method performed on different hollow fibers 
The preferred method using 10 ml 5 M sodium hydroxide in 1,1 L water as donor phase (pH 
12.65), dihexyl ether as organic phase and water adjusted to pH 2 with formic acid as 
acceptor phase was used to test different types of hollow fibers. The tested hollow fibers are 
made of the same material but the maximum pore size (µm) and other parameters e.g. wall 
thickness and diameter differed.  
Until now fiber P1 LX has been used to perform the extractions using different organic 
phases, donor phases and acceptor phases. It was decided to try two different fiber types in 
order to optimize the method, and determine which fiber performs the best extraction of the 
selected analytes.  
The tested fibers PP Q3/1 and PP Q3/2 had twice the length of fiber P1 LX. In order to fit 
into the 1000 ml glass bottle these fibers were divided into two equal- sized parts, 27 cm.  
The extraction was carried out as previously described. 7 parallels containing 50 ng analytes 





5.1.6 Acidic hydrolysis of alprazolam, 1- hydroxy alprazolam, clonazepam and 
7- aminoclonazepam? 
Ugland et al. has previously performed LPME extraction of some selected weakly basic 
benzodiazepines from whole blood. According to this article some of their investigated 
benzodiazepines (nitrazepam, alprazolam, N- desmethyldiazepam and diazepam) undergo 
acidic hydrolysis in an aqueous solution. This hydrolysis is creating long- or short- lived 
intermediates (ring opening) see figure 10. The intermediates further degrade to the end 
product benzophenone[23].   
During the method development for extraction of the selected benzodiazepines four analytes 
were not extracted; alprazolam, 1- hydroxy alprazolam, clonazepam and  
7- aminoclonazepam. After reading this article it was decided to dissolve these analytes in 
three different solutins; pure Millipore water, water adjusted to pH 2 with formic acid and 
water adjusted to pH 10,5 with ammonia. In order to exclude basic hydrolysis of clonazepam 
and 7- aminoclonazepam the analytes were added to the basic solution. The three solutions 
were then injected to the UPLC-MS/MS.     
 
Even though the analytes in all three solutions were detected on the MS it was decided to 
obtain a full scan of the solution made with water adjusted to pH 2 with formic acid. It was 
suspected to find some of the hydrolyzed products in the solution because of the obtained 
equilibrium between the analytes and there product.  
The protonated molecular ion 327 and 343 were suspected to be found for alprazolam and  
1- hydroxy alprazolam.  
The protonated molecular ion 334 and 304 (clonazepam and 7- aminoclonazepam) were also 
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 Figure 7: Molecules searched for in the obtained full scan. 
 
 






6 MS/MS- analysis 
6.1 Equipment 
The detection was carried out on a Quattro Premier XE, Waters (Milford, MA,USA).  
Sofware: Masslynx XT (Micromass) 




Each compound was infused separately by a Hamilton syringe (250 µl) to the MS for 
detection of the molecular and product ions.   
The m/z signal was optimized by changing the Cone Voltage until the signal was considered 
optimal. Cone Voltage was increased with increments of 5 V and fine-tuned until the optimal 
signal was found. All other terms were kept constant (see table 1). For detection of the 
product ions, MS/MS-scan was performed. Collision Energy (CE) was varied until optimal 










Table 1: Optimal terms for MS and MS/MS- analysis 
Terms Single MS MS/MS 
Flow(µl/min) 20 20 
ESI- mode Positive Positive 
Capillary (kV) 3,30 3,30 
Cone (V) Se table 2 Se table 2 
Extractor (V)  2 2 
RF lens (V) 0,2 0,2 
Temp source (ºC) 100 100 
Temp desolvetion (ºC) 250 250 
Cone gas flow (L/hr) 20 20 
Desolvation gas flow(L/hr) 100/200* 100/200* 
LM Resolution 1 15 15 
HM Resolution 1 15 15 
Ion energy 1 1 
Entrance 30 0 
Collision 2 Se table 2 
Exit 30 0 
LM Resolution 2 14,5 14,5 
HM Resolution 2 14,5 14,5 
Multiplier 650 650 
* 200 L/hr used during UPLC- MS/MS 
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Table 2: Dwell, optimal CV and CE for the protonated molecular ions and product ions. 
  [M+H]+ Product ion CV CE Dwell 
Clonazepam 316,19 270,03 38 23 0,5 
7-Aminoclonazepam 286,19 250,20 39 20 0,5 
Zoplidem 308,31 235,11 48 33 0,5 
Zolpidem- d6 (IS) 314,31 235,04 52 38 0,1 
Alprazolam 309,21 281,10 48 25 0,5 
1-Hydroxy Alprazolam 324,23 295,18 42 25 0,5 
Alprazolam 5-Oxide 325,00 205,00 34 27 - 
Midazolam 326,25 291,08 52 27 0,5 
Midazolam- d5 (IS) 331,29 296,25 56 27 0,1 
1-Hydroxy Midazolam 342,25 323,98 45 20 0,5 
Zopiclone 389,23 245,18 22 18 - 
Zopiclone- d8 (IS) 397,10 245,00 20 18 - 
Zopiclone N-oxide 405,05 143,20 26 15 - 
N- desmethyl Zopiclone 
Hydrochloride 














The mass spectra obtained of alprazolam 5-oxide and zopiclone N-oxide was poor, it was not 
possible to find the best fragment ion. These analytes were therefore excluded from the 







7 Separation by UPLC 
7.1 Equipment 
The analysis was carried out by a Wates nano Acquity Ultra Performance LC. 
Chromatographic separation was performed by a reverse phase, acquity UPLC® BEH C18 
1,7µm, 1,0x150mm column from Waters. 
7.2 Experimental  
Protonated molecular ion, product ion, CV and CE, detected during MS/MS-analysis, were 
set up in the Multiple Reaction Monitoring (MRM) method of Masslynx. A mixture of all 
analytes, in known concentrations, was injected to the UPLC- MS/MS. The samples were 
injected in a volume of 5µl. The retention time for each compound was found and optimized 
by testing different gradients of the mobile phase. The optimal gradient was chosen and the 
retention time for each compound was plotted in to the MRM method. The MRM parameters 
used were kept constant (see appendix 14.2). The optimal situation is when the gradient 
separates the analytes properly so that the MS only focuses on a small number of analytes in 
each selected retention window (see table 4). In these retention windows the MS is focused 
only on the specific protonated molecular ion and product ion, while all other are excluded. 
In a MRM method the transition between the protonated molecular ion and the product ion is 
monitored by rapid switching of the electric fields applied to the mass analyzer to study each 
transition in turn. The MRM method provides an optimal sensitivity and much lower noise 
than the Single Ion Monitoring (SIM) method. MRM can result in a lower limit of detection 
than can be achieved in SIM because of the higher degree of specificity in MRM. On the 
other hand SIM provides higher peak areas[24, 25].  
The first mobile phase tested consisted of Millipore water (solution A) and acetonitrile 
(solution B), used in a linear gradient. This mobile phase was not found optimal for elution of 
the analytes in the mixture, tailing was observed at some of the chromatograms. After this 
observation it was decided to try another composition of the mobile phase.  
The new mobile phases consisted of Solution A; Millipore water and 0,1 % formic acid and 
solution B; 90 % acetonitrile, 10 % Millipore water and 0,1 % formic acid.  
The retention time for the analytes changed when formic acid was added to the solutions and 
the problem with tailing improved. The change in retention time was corrected in the MRM 
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method but the gradient was kept the same (table 3). Within 16 minutes all analytes were 
eluted (table 4).  
Table 3: Line, optimal flow and gradient  
Solution A; Millipore water : 0,1 % formic acid  
solution B; 90 % acetonitrile : 10 % Millipore water : 0,1 % formic acid.  
Minutes Gradient %  
solution A:B 
Flow (µL) Line 
0 80: 20 50 - 
10 60: 40 50 6 
20 20: 80 50 6 
 
Table 4: Retention window for the analytes using the optimal gradient. 
Analytes Retention window (min.) 
7-Aminoclonazepam 3 - 7 
1-Hydroxy Alprazolam 7 – 9 
Zolpidem- d6 7 – 9 
Zolpidem 7 – 9 
Midazolam 9 – 13 
Midazolam- d5 9 – 13 
1-Hydroxy Midazolam 9 – 13 
Alprazolam 13 - 16 




8 Preparation of the sample before extraction 
The optimized method was performed on sampled sewage water.  
These samples were taken by an automatic sampling system.   
The sewage water was then measured into 1,1 L samples and  added a given concentration of 
the internal standards, zolpidem- d6 (25 ng) and midazolam- d5(100 ng) . 10 ml 5 M sodium 
hydroxide was also added to make the sample basic. By adding a known concentration of 
internal standards, calculation of the concentration of unknown analytes could be performed 
by using the extracted standard curves.  
The sample was then filtered through two glass microfiber filters (particle retention: 1,2 µm). 
This filtration removed particles and other unwanted objects from the water. Filtration may 
reduce the results of the amount analytes found in the sample, only the unbounded fraction of 
the analytes is measured. Due to a previous observation of Dr. Terje Vasskog it was decided 
necessary to filter the sewage water. During his work with HF- LPME extraction of basic 
analytes (SSRI`s) it was observed that a biofilm was developed on the outside of the 














9 Optimized method performed on sewage water 
A hollow fiber (Capillary Membrane, polypropylene, P1 LX) with an inner diameter of  
330 µm, wall thickness of 150 µm, and max pore size 0,47µm, was used to connect two  
0,5 x 16mm Terumo medical syringe needles( 25G x 5/8”). The hollow fiber was dipped in 
an organic solvent, dihexyl ether, for about 20 seconds to fill the pores. Then an ultrasonic 
bath was used for about 3 seconds to remove excess solvent. After every third fiber, the water 
in the ultrasonic bath was changed. A 1 mL syringe was then attached to one of the medical 
syringes and used to fill the lumen of the hollow fiber with approximately 25µl acceptor 
solution (water adjusted to pH 2 with formic acid). The medical syringe needles were then 
removed and the ends of the hollow fibre were closed by a thin copper wire.  
The HF- LPME was carried out in a 1000 ml glass bottle. Screw cap with septum was used to 
close the bottle. A 0,8 mm syringe was inserted through the septum, and a thin metal wire 
was used to hold the fiber down in the water during the extraction. The extraction was carried 
out with stirring at 800 rpm for 2 hours.   
After the extraction the acceptor solution was collected in a UPLC autosampler vial. This was 
done by attaching a 1 mL syringe with a medical syringe needle to one end of the fiber before 
air was used to push the acceptor phase through the fiber into the vial. The acceptor solution 
was directly injected to the LC-MS/MS. Each fiber was only used once. 
 
Extraction of a blank sample 
A blank sample, sample without analytes, was extracted in order to confirm that the tap water 
used for extraction of the standard curves was not contaminated with benzodiazepines. The 
extraction was performed as previously described. 1,1 liter tap water was adjusted to pH 
12.65 with sodium hydroxide (donor phase), dihexyl ether was used as organic phase and 
water adjusted to pH 2 with formic acid was used as acceptor phase. 
Blank samples like this are used to ensure that the method is not influenced by the personal or 
chemicals present in the extraction method e.g. dihexyl ether, sodium hydroxide and formic 
acid.         
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Standard curves  
Several of the selected benzodiazepines in this method development were not extracted using 
the optimized method. Zopiclone and its metabolites experienced basic hydrolysis and were 
therefore excluded from this method development. Alprazolam, 1-hydroxy alprazolam, 
clonazepam and 7-aminoclonazepam may not have been sufficiently ionized or been 
hydrolysed in the acidic acceptor phase.  
 
The optimized method was used and performed as previously described in order to make a 
standard curve for; midazolam, 1- hydroxy midazolam and zolpidem.  
The selected internal standards should have a similar behaviour as the analyte and are added 
in a known concentration in order to adjust for random alterations during the extraction. 
1,1 L tap water added 10 ml 5 M sodium hydroxide (pH 12.65) was used as donor phase, 
dihexyl ether as organic phase and water adjusted to pH 2 with formic acid was used as  
acceptor phase. Midazolam- d5 (100 ng) and zolpidem- d6 (25 ng) was used as internal 
standards. 
Each concentration of analyte 250- 100- 50- 25- 10 and 1 ng was extracted with 6 parallels in 









Calculation of LOD and LOQ 
The extraction of the standard curves, 6 batches, was used to calculate LOD and LOQ for the 
extracted analytes zolpidem, midazolam and 1- hydroxy midazolam.  
1-hydroxy midazolam was not detected in the lowest concentration of 1 ng analytes, LOD 
and LOQ was therefore calculated from the extraction using 10 ng analytes. 
The calculation was performed by measuring the height of the noise and the height of the 
signal, these measurements were put in to the following formulas used for calculation: 
 
LOD= concentration analyte(ng/1,1L) x 3 x Noise (cm)  = X ng/1,1L 
                                                                       Signal (cm) 
 
LOQ = concentration analyte (ng/1,1L) x 10 x Noise (cm) = X ng/1,1 L 












10 RESULTS AND DISCUSSION 
10.1.1 Hydrolysis of Zopiclone and metabolites  
HF-LPME is not a successful extraction method for zopiclone and its metabolites. The 
injection of the three solutions into the LC-MS/MS, revealed that during the extraction the 
ananlytes undergo basic hydrolysis (see figure 9). When injecting the sample with water 
adjusted to pH 10,5 with ammonia there were no signal of the molecules(see chromatogram 
3). The sample made with Millipore water and the last sample of water adjusted to pH 2 with 
formic acid gave signal (see chromatogram 1 and 2). This underlines the assumption that a 
basic hydrolysis occur. 
Structurally zopiclone and its metabolites have a similar ground structure, but they do have a 












Figure 8: Ground structure of zopiclone and its metabolites   
 
By using full scan, in the search for the different side chains (m/z), R, the MS was not able to 
separate zopiclone from its metabolites. Zopiclone and its metabolites were therefore 



















































Figure 9: Basic hydrolysis of zopiclone. The same reaction occurs for its metabolites[26]. 
 
By searching for the different molecular ions made during the hydrolysis, protonated 
molecular ion 129 was detected within the full scan chromatogram (chromatogram 4).  The 
protonated molecular ion 153, 145, 131 and 161 were not detected. This could be due to poor 





Chromatogram 1: Zopiclone, zopiclone- d8 and N-desmethyl zopclone dissolved in Millipore water. 
 
 
Chromatogram 2: Zopiclone- d8, zopiclone and N-desmethyl zopiclone dissolved in water adjusted to pH 2 





Chromatogram 3: Zopiclone- d8, zopiclone and N-desmethyl zopiclone dissolved in water adjusted to 
 pH 10,5 with ammonia.  
 Zopiclone and metabolites solved in NH3 
56
Chromatogram 4: Protonated product ion 129 found in the obtained full scan. Zopiclone, zopiclone- d8 and  
N- desmethyl zopiclone dissolved in water adjusted to pH 10,5 with ammona. 
Time 
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5.43 5.22 12.315.45 11.4610.516.08 






10.1.2 Extraction using different organic phases 
Extraction using different organic phases was carried out with varying results.  
1- octanol,  3- octanol and Dihexyl ether used as extraction media 
n- octanol and dihexyl ether are among the organic solvents traditionally used during LPME. 
These organic solvents are known to have good extraction qualities, low polarity and 
viscosity[22].  
During extraction with 1- octanol, air bubbles occurred on the outside of the fibers. 
These air bubbles could indicate high stirring speed, or it could be a result of the large 
amount of sample extracted (donor phase). The organic phase could have been washed out 
into the sample. Without organic phase immobilized in the pores of the hollow fiber no 
extraction will occur.  
Neither 3- octanol was suited as organic solvent. When air was pushed through the fiber for 
collection of the acceptor phase, there was no sample in the fiber. As the air was pushed 
through, the sample came out the walls of the fiber. This can indicate leakage of the organic 
phase into the donor phase due to long extraction time and poor immobilization in the pores 
of the hollow fiber.  
The distribution coefficient (log- D) of the organic solvents affects the quality to perform 
extraction.  The higher distribution coefficient the more hydrophobic is the solvent/molecule.  
1- octanol has an log- D of 3 and 3- octanol 2,82 at 25ºC[27]. Dihexyl ether has a log- D 
value of 5,23 which is higher than for the two octanole solvents used. The difference in the 
log- D values of the selected organic solvents may participate in the poor extraction results 
using 1- and 3- octanol. A low log –D value of the organic phase will make it more 
hydrophilic which could result in wash out from the fibres into the sample.  







Volatile oils used as extraction media 
Peppermint oil and eucalyptus oil performed poor extraction of the selected analytes. 
According to the producer of peppermint oil and eucalyptus oil, Pharmacy Production in 
Oslo, there may be some remains of solvents used during the production. Steam distillation, 
used for production of these volatile oils, uses some water soluble components e.g. ethanol. 
Some of these water soluble components may be found in the end product and influence the 
quality as organic phase during HF- LPME. High polarity of the organic phase could lead to 
leakage into the large sample amount and thereby perform poor extraction. 
Peppermint oil and eucalyptus oil may not be retained with sufficient strength in the pores of 
the hollow fibre. The large sample amount (1,1L) and long time of extraction could intensify 
the leakage into the donor phase. 
Peppermint oil and eucalyptus oil have previously successfully been used as organic phase in 
small sample amounts of water, plasma and urine (0,2 – 1 ml)[22].  
For average area after extraction and chromatograms see appendix 14.3 and 14.4.     
 
Essential oils used as extraction media 
Both Almond and peanut oil performed HF-LPME successfully. 1-hydroxy midazolam, 
midazolam- d5, miadzolam, zolpidem and zolpidem- d6 were all extracted using these 
essential oils. The average area after extraction with almond oil and peanut oil were poorer 
than extraction performed with dihexyl ether. Dihexyl ether was therefore preferred.  
For average area after extraction and chromatograms see appendix 14.3 and 14.4.   






Plant oils used for cooking as extraction media 
Four plant oils usually used for cooking, sunflower oil, corn oil, sesame oil and rape( seed) 
oil were immobilized in the pores of the hollow fiber as organic phase. All four tested plant 
oils succeeded as organic phase. Unfortunately the area under the curve was lower than using 
dihexyl ether, one of the traditional solvents used in LPME.   
Corn oil was the plant oil that performed the best extraction of the four tested oils. Rape 
(seed) oil was observed to perform the poorest extraction of the different plant oils tested. 
During the extraction work it was observed that Rape (seed) oil has a higher viscosity than 
Corn oil. High viscosity could influence and limit the diffusion rate of analytes across the 
organic phase.  
Pedersen- Bjergaard and Rasmussen have suggested that hydrolysis of fatty oils may occur 
when the extraction time are prolonged over 45 minutes [22].     
During the extraction of the selected benzodiazepines using plant oils it was observed that the 
polypropylene hollow fibers had a more spongy appearance after the extraction. This could 
indicate that a hydrolysis of the fatty oils (saponification) may have occurred in some degree 
and resulting in poorer extraction. The fatty oils used are in contact with the base for a longer 
time (2 hours) and the volume of basic donor phase are larger than the sample used in 
Pedersen- Bjergaards and Rasmussens extraction. These parameters may contribute to 
hydrolysis in some degree.Fatty acids could undergo saponification in contact with sodium 
hydroxide. The ester groups are hydrolyzed and produce glycerol and fatty acid salts (e.g. see 
figure 10). 


































Dihexyl ether performed better extraction than the selected plant oils. The poorer extraction 
using plant oils may be caused by saponification or other extraction limiting factors like 
viscosity. For average area after extraction and chromatograms see appendix 14.3 and 14.4.  
10.1.3 Extraction using different bases as donor phase 
Clonazepam, 7- aminoclonazepam, alprazolam and 1- hydroxy alprazoalm were not extracted 
using water adjusted to pH 12.65 with sodium hydroxide as a donor phase. It was therefore 
decided to try different pH levels and different bases in the donor phase.    
Extraction performed using water adjusted to pH 11 with ammonia and 100 ng analytes as the 
donor phase was no success. 1-hydroxy midazolam, midazolam- d5, midazolam, zolpidem 
and zolpidem- d6 were detectable in the sample but not quantifiable. Ammonia is a weaker 
base than sodium hydroxide, this may contribute to a lower performance of extraction. The 
sample might not have been sufficiently alkaline for extraction of the basic analytes.  
 
Sodium hydroxide was used as donor phase with success.  
Water adjusted to pH 12.65 with sodium hydroxide performed the HF-LPME extraction with 
the best result at the lowest added concentration (50 ng /1,1L) analytes. Water adjusted to pH 
13.95 with sodium hydroxide as donor phase gave the best extraction results with 
concentrations over 100 ng analytes. To my best knowledge there has not been found 
concentrations higher than 50 ng /1,1L in sewage water samples. It was therefore decided to 
use water adjusted to pH 12.65 with sodium hydroxide as donor phase.  
Clonazepam, 7- aminoclonazepam, alprazolam and 1- hydroxy alprazolam were not extracted 
using the selected bases and pH- levels.  
For average area after extraction and chromatograms see appendix 14.3 and 14.4. 
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10.1.4 Extraction using different acids as acceptor phase  
Acceptor phase using water adjusted to pH 2 with hydrochloric acid performed extraction of 
the analytes in some degree, but not consistent.  
The extraction using water adjusted to pH 1 with hydrochloric acid extracted the analytes 
sufficiently and the area under the curve was consistent.  The analytes were probably 
sufficiently ionized and therefore captured in the acceptor phase for detection. Hydrochloric 
acid is a stronger acid than formic acid but it was not found good enough to perform 
extraction of clonazepam, 7- aminoclonacepam, alprazolam and 1-hydroxy aloprazolam.  
The average area after extraction was nearly the same using water adjusted to pH 1 with 
hydrochloric acid and water adjusted to pH 2 with formic acid.  
Water adjusted with formic acid performed the extractions to some degree better than water 
adjusted to pH 2 with hydrochloric acid. This solution was there for found to be the optimal 
acceptor phase. Formic acid is a weaker acid than hydrochloric acid and considered more 
compatible with the mobile phase and the UPLC- MS system. For average area after 
extraction and chromatograms see appendix 14.3 and 14.4.   
10.1.5 Optimized method performed on different hollow fibers 
All three fibers performed the HF-LPME extraction with good results. Fiber PP Q3/2 
performed best extraction for 1- hydroxy midazolam and midazolam.  
Midazoalm- d5, zolpidem and zolpidem- d6 had best extraction using fiber P1 LX.  
Fiber PP Q3/2 has a max pore size of 0,63 µm, which is higher than the rest of the fibers used 
in this method development. The different pore sizes of the fibers may influence the ability to 
extract. It may take longer time to immobilize the organic phase in the pores of the hollow 
fiber. It was noticed that the variations of results was greater within the two fibers PP Q3/1 
and PP Q3/2. These high variations of the parallels may be caused by poor immobilization of 
organic phase in some fibers or the fact that the wall of the hollow fibers, PP Q3/1 and PP 
Q3/2, are thicker (200µm) than the little fiber P1 LX (150 µm).  
The extraction time of two hours may not be sufficient in order to achieve equilibrium with a 
wall thickness of 200 µm this may also influence the consistency. 
The lumen of fiber PP Q3/1 and PP Q3/2 hold a larger acceptor phase volume than fiber P1 
LX. Fiber PP Q3/1 holds approximately 72 µl while fiber PP Q3/2 holds 33µm and P1 LX 25 
µl. A large volume of acceptor phase injected to the LC- system could provide better LOD 
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and LOQ[17]. 
For average area after extraction and chromatograms see appendix 13.3 and 13.4.   
10.1.6 Acidic hydrolysis of alprazolam, 1-hydroxy alprazolam, clonazepam and 
7- aminoclonazepam? 
 
The suspected hydrolysis of alprazolam, 1- hydroxy alprazolam, clonazepam and  
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 Figure 11: E.g. acidic hydrolysis of alprazolam[29]. 
 
The injection of the three solutions into the LC-MS/MS, revealed that no acidic or basic 
hydrolysis had occurred. It was possible to detect alprazolam, 1- hydroxy alprazolam, 
cloazepam, 7- aminoclonazepam in the solutions made of pure Millipore water, water 
adjusted to pH 2 with formic acid and water adjusted to pH 10,5 with ammonia. See 
chromatogram 5-7.  
The mechanism of the acidic hydrolysis is in an equilibrium between molecule  
1 and 2 (see figure 11). Because of the equilibrium it was decided to search for the protonated 




Chromatogram 5: Clonazeam, alprazolam, 1- hydroxy alprazolam and 7- aminoclonazepam dissolved in 
Millipore water. 
 
Chromatogram 6: Clonazepam, alprazolam, 1- hydroxy alprazolam and 7- aminoclonazepam dissolved in 




Chromatogram 7: Clonazepam, alprazolam, 1- hydroxy alprazolam and 7- aminoclonazepam dissolved in 
water adjusted to pH 10,5 with ammonia. 
 
The searches for the suspected product ions after hydrolysis of alprazolam and 1- hydroxy 
alprazolam were detectable in the obtained full scan.  
E.g. ion [M+H]+ 327.21 for the hydrolyzed alprazolam product (according to figure 11) was 





Chromatogram 8: E.g. molecular ion 327.21 found in the obtained full scan. Alprazolam, 1- hydroxy 
alprazolam, clonazepam and 7- aminoclonazepam dissolved in water adjusted to pH 2 with formic acid. 
 
Protonated molecular ions from hydrolyzed clonazepam and 7-aminoclonazepam were not 
found in the obtained full scan.  
 
Low pKa- values of alprazolam, 1- hydroxy alprazolam, clonazepam and  
7- aminoclonazepam may also contribute to poor extractioon. These analytes may not have 
been sufficiently ionized to immobilise the analytes in the acceptor phase. 
The acceptor phase should be at least 3.3 pH units below the pKa of basic analytes to perform 
extraction[23].  
Clonazepam, 7- aminoclonazepam, alprazolam and 1-hydroxy alprazolam has all  











Extraction of a blank sample 
The blank sample extracted did not reveal benzodiazepines in the water. This indicates that 
the method is not influenced by other chemicals like formic acid present in the extraction, and 
that the equipment and the personal do not contaminate the sample. See appendix 14.5.  
Standard curves 
The standard curves were plotted by calculating the ratio analyte over internal standard. This 
was then plotted against the concentration of added analyte. All three extracted standard 
curves were calculated to have a difference quotient of 0.99 (see appendix 14.1).   
1- hydroxy midazolam was not extracted at the lowest concentration 1 ng/ 1,1 L. The lowest 
concentration for this analyte is therefore 10 ng/ 1,1L sample.  
 
 





Calculation of LOD and LOQ 
Calculation of LOD and LOQ was performed as previously described.  
 
Table 5: Limit Of Detection and Limit Of Quantification for the extracted analytes using HF-LPME. 
Water adjusted to pH 12.65 with sodium hydroxide used as base in the donor phase, dihexyl ether as organic 
phase and water adjusted to pH 2 with formic acid as acceptor phase. 
Analytes  LOD LOQ 
Zolpidem 0,2 ng/1,1L 0,7 ng/1,1L 
Midazolam 0,3 ng/1,1L 1,1 ng/1,1 L 
1- Hydroxy Midazolam 4,7 ng/1,1 L 15,9 ng/1,1L 
 
1- hydroxy midazolam has a higher LOD and LOQ- value than zolpidem and midazolam. 
The high LOD and LOQ- value indicate why 1- hydroxy midazolam not were detected in the 
concentration of 1 ng added analytes.  
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Extracted sewage water samples   
Analyses of collected sewage water were performed in January and April.  
The extraction performed in January had quantifiable results for zolpidem.  
1- hydroxy midazolam and midazolam were detectable. For chromatograms see appendix 
14.6.   
In April none of the extractions performed had quantifiable results, but 1- hydroxy 
midazolam, zolpidem and midazolam were detectable. The difference in result between these 
months could be due to the high ice melting in April. The low amount of analytes found in 
the samples taken in April is therefore most truly due to dilution of the sewage by melt water.  
 
Benzodiazepines are intended for short time use and the dosages administered are generally 
lower than for e.g. antidepressants that are usually intended for a longer period of time. 
Benzodiazepines are mostly prescribed in dosages of 5– 20 mg daily, while antidepressants 
usually are prescribed in dosages of 20- 200 mg depending on the activity of the drug and 
severity of the medical condition[30]. It is therefore suspected to find lower concentrations of 
benzodiazepines in environmental samples compared to antidepressants. Citalopram and 
sertralin are among the most prescribed antidepressants used in Norway. In Troms 2008 it 
was registered that 421479 defined daily dosages (DDD) citalopram had been used, 242094 
DDD sertralin.  
Zopiclone is the most prescribed benzodiazepine in Norway. In 2008 1226260 DDD of 
zopiclone were purchased from pharmacies in Troms. Unfortunately zopiclone is among the 
analytes that were not extracted using HF-LPME due to basic hydrolysis of the compound.  
Zolpidem are the second most prescribed benzodiazepine, 153378 DDD[31]. At Langnes 
STP it was possible to quantify the amounts zolpidem found (3 ng/ L sewage water) in 
samples taken in January. Based on sale statistic it is likely to find higher concentrations of 




Table 6: Table of concentration, detectable (D) and not detectable (ND) analytes in samples collected and 













Zolpidem was the only quantifiable analyte found in the waste water collected at Langnes in 
January. The concentration was calculated to be 3 ± 2,7  ng /L waste water. The high standard 
deviation of the samples extracted (four parallels) could be a result of the low analyte 
concentration in the sample. The analytical results differ more widely when the concentration 
of analytes is low.  
 
Analytes  January April 
7-Aminoclonazepam ND ND 
1-Hydroxy Alprazolam ND ND 
Zolpidem- d6 Internal Standard Internal Standard 
Zolpidem 3 ± 2,7 ng / L waste water D 
Midazolam D D 
Midazolam- d5 Internal Standard Internal Standard 
1-Hydroxy Midazolam D D 
Alprazolam ND ND 










Extraction using water adjusted to pH 12.65 with sodium hydroxide as donor phase, water 
adjusted to pH 2 with formic acid as acceptor phase and dihexyl ether as organic phase 
became the preferred method. Hollow fiber (Capillary Membrane, polypropylene) with an 
inner diameter of 330 µm, wall thickness of 150 µm, and max pore size 0,47µm was found to 
perform the best and the most reproducible extraction of the analytes. Zolpidem, zolpidem- 
d6, midazolam, midazolam –d5 and 1-hydroxy midazolam were sufficiently extracted for 
quantification. Zopiclone, zopiclone- d8, N-desmethyl zopiclone, clonazepam,  
7- aminoclonazepam, alprazolam, 1-hydroxy alprazoalm, zopiclone, zopiclone-d8, zopiclone-
N-oxide and N-desmetyl zopiclone hydrochloride were not extracted using HF-LPME as 
extraction method.  
The optimized method of HF-LPME was suited for the extraction and pre-concentration of 
some basic benzodiazepines in sewage water. 1- hydroxy midazolam and midazolam were 
detectable and zolpidem was found quantifiable in samples taken in January. In April neither 
of the analytes was quantifiable but they were all detectable. 
 
Extraction with non synthetic organic solvents like plant oils as organic phase is preferable. 
Synthetic organic solvents like 1- octanol and dihexyl ether are relative expensive and 
provides a higher health risk of the laboratory personnel and environment compared to plant 
oils and other non synthetic organic solvents. The tested plant oils and essential oils 
performed the extraction, but because dihexyl ether provided better extraction results it was 
preferred as organic phase. 
HF-LPME may not be an optimal extraction method for all analytes. Easily hydrolysed 
groups within the analytes, which may undergo basic or acidic hydrolysis, should be 






12 FUTURE PERSPECTIVES 
In order to asses the consequences of pharmaceuticals in the environment more biological 
testing of effects should be performed. All pharmaceuticals are constructed to possess 
reactive groups known to interact with specificity in the body. But the knowledge on their 
toxic effect on biological systems in the environment needs more attention.  
Some of the studied benzodiazepines; clonazepam, 7- aminoclonazepam, alprazolam,  
1-hydroxy alprazoalm, zopiclone, zopiclone-d8, zopiclone- N-oxide and N-desmetyl 
zopiclone hydrochloride were not extracted using the developed HF-LPME method.  
An extraction method that previously has been found to perform extraction of these analytes 
is solid phase extraction (SPE). An extraction method for zopiclone and its metabolites from 
human plasma have been demonstrated by Mistri et al.[32]. In order to detect zopiclone in 
environment environmental samples it is suspected that SPE is a better extraction and pre-
concentration method. Future analysis of benzodiazepines in environmental samples should 
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14 APPENDIX  
14.1 Linearity of Standards 





















































































14.2 Multiple reaction monitoring parameters 
Dwell time: 0,1 sec.(internal standards) – 0,5 sec. (analytes). 
Inter channel delay: 0,01 sec. 
Inter scan delay: 0,02 sec. 
Repeats: 1 






14.3 Average area after extraction 
 
Table 7: Different organic phases tested. Water adjusted to 12.65 with sodium hydroxide (pH 12.65) was used 
as donor phase and water adjusted to pH 2 with formic acid as acceptor phase 
Concentration  



















1- Octanol 3- Octanol 
50 ng 1-Hydroxy 
Midazolam 
121 209 187 136 155 144 417 - - - - 
 Midazolam-d 5 288 414 278 228 415 266 1480 - - - - 
 Midazolam 1293 2176 1480 1309 1651 1241 5770 - - - - 
 Zolpidem 197 514 387 304 240 279 1224 - - - - 
 Zolpidem- d6 341 803 565 467 256 392 1912 - - - - 
100 ng 1- Hydroxy 
Midazolam 
352 372 366 260 351 219 1250 - - - - 
 Midazolam- d5 820 902 725 465 866 426 4481 - - - - 
 Midazolam 3691 4267 3807 2708 3558 2461 15440 - - - - 
 Zolpidem 643 970 788 487 595 335 25440 - - - - 
 Zolpidem- d6 1040 1439 1223 798 939 619 3689 - - - - 
250 ng 1- Hydroxy 
Midazolam 
787 1024 803 715 943 576 2312 - - - - 
 Midazolam- d5 1403 1949 1469 1313 2322 1501 9495 - - - - 
 Midazolam 11035 10923 6977 7188 9642 7166 30375 - - - - 
 Zolpidem 1968 3243 1722 1329 1731 1118 6975 - - - - 
 Zolpidem- d6 3086 5112 2808 2074 2526 1730 9109 - - - - 
___________________________________________________________________________ 
Table 8: Different donor phases tested. Water adjusted to pH 2 with formic acid was used as acceptor phase and 




Average area after extraction 
   Concentration 
analytes 
 added 
Analytes Water adjusted to 
pH 12.65 with 
sodium hydroxide 
Water adjusted to 





pH 11 with 
ammonia 
  50 ng 1-Hydroxy Midazolam 417 134 - 
 Midazolam-d5 1480 976 - 
 Midazolam 5770 5583 - 
 Zolpidem 1224 8946 - 
 Zolpidem- d6 1912 16583 - 
100 ng 1-Hydroxy Midazolam 1250 411 - 
 Midazolam- d5 4481 4054 - 
 Midazolam 15440 19795 - 
 Zolpidem 2558 19114 - 
 Zolpidem- d6 3689 33282 - 
250 ng 1-Hydroxy Midazolam 2312 1139 - 
 Midazolam- d5 9495 10823 - 
 Midazolam 30375 47764 - 
 Zolpidem 6975 48584 - 





Table 9: Different acceptor phases tested. Water adjusted to pH 12.65 with sodium hydroxide was used as 
donor phase and dihexyl ether as organic phase 
 Average area after extraction 




pH 2 with 
formic acid 
Water adjusted to 
pH 1 with 
hydrochloric acid 
 
Water adjusted to 
pH 2 with 
hydrochloric acid 
 
50 ng 1-Hydroxy Midazolam 417 432 - 
 Midazolam- d5 1480 574 - 
 Midazolam 5770 2415 - 
 Zolpidem 1224 1228 - 
 Zolpidem- d6 1912 1593 - 
100 ng 1-Hydroxy Midazolam 1250 851 - 
 Midazolam- d5 4481 1050 - 
 Midazolam 15440 4348 - 
 Zolpidem 2558 2521 - 
 Zolpidem- d6 3689 3501 - 
250 ng 1-Hydroxy Midazolam 2312 2371 - 
 Midazolam- d5 9495 3159 - 
 Midazolam 30375 12609 - 
 Zolpidem 6975 5761 - 





Table 10: Different hollow fibers tested. Water adjusted to pH 12.65 with sodium hydroxide was used as donor 
phase, dihexyl ether as organic phase and water adjusted to pH 2 with formic acid was used as acceptor phase. 
 
 Average area after 
extraction 








50 ng 1-Hydroxy Midazolam 417 901 1029 
 Midazolam- d5 1480 1287 1453 
 Midazolam 5770 5400 6185 
 Zolpidem 1224 71 179 











14.4 Chromatograms of different organic phases, donor phases, 
acceptor phases and fibers tested during method optimization  
Different organic phases tested 
 










Chromatogram 12: MRM chromatogram. Peppermint oil used as organic phase. 100 ng analytes added the 
donor phase. 
 






Chromatogram 14: MRM chromatogram after smoothing. Peanut oil used as organic phase. 100 ng analytes 
added the donorphase. 
 
 
Chromatogram 15: MRM chromatogram after smoothing. Almond oil used as organic phase. 100 ng analytes 





Chromatogram 16: MRM chromatogram after smoothing. Corn oil used as organic phase. 100 ng analytes 
added the donor phase.  
 
Chromatogram 17: MRM chromatogram after smoothing. Rape (seed) oil used as organic phase. 100 ng 





Chromatogram 18: MRM chromatogram after smoothing. Sesame oil used as organic phase. 100 ng analytes 
added the donor phase. 
 
Chromatogram 19: MRM chromatogram after smoothing. Sunflower oil used as organic phase. 100 ng 








Chromatogram 20: MRM chromatogram after smoothing. Water adjusted to pH 13.95 with sodium ydroxide  h
and added 100 ng analytes used as donor phase.  
 
Chromatogram 21: MRM chromatogram after smoothing. Water adjusted to pH 11 with ammonia and added 
100 ng analytes used as donor phase. 
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Different acceptor phases tested 
 
Chromatogram 22: MRM chromatogram. Water adjusted to pH 2 with hydrochloric acid used as acceptor 
phase. 100 ng added the donor phase 
 
Chromatogram 23: MRM chromatogram after smoothing. Water adjusted to pH 1 with hydrochloric acid used 








Chromatogram 24: MRM chromatogram after smoothing.  
Fiber PP Q3/1 tested. W  donor phase, dihexyl 
e  
ater adjusted to pH 12.65 with sodium hydroxide was used as
ther as organic phase and water adjusted to pH 2 with formic adic was used as acceptor phase. 50 ng analytes




Chromatogram 25: MRM chromatogram after smoothing.  
Fiber PP Q3/2 tested. Water adjusted to pH 12.65 with sodium hydroxide was used as donor phase, dihexyl 






Chromatogram 26: MRM chromatogram after smoothing.  
Fiber P1 LX tested. Water adjusted to pH 12.65 with sodium hydroxide was used as donor phase, dihexyl ether 
as organic phase and water adjusted to pH 2 with formic adic was used as acceptor phase. 50 ng analytes were 




14.5 Extraction of a blank sample 
 
Chromatogram 27: MRM chromatogram of blank sample. 
93
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14.6 Extracted sewage water  
Chromatogram 28 : MRM chromatogram after smoothing. Waste water added a given concentration internal 
standards (25 ng zolpidem- d6 and 100 ng midazolam- d5). Sample taken in January. 
94
